RECLAIM is an adaptive platform randomized trial comparing the effectiveness of various interventions for lingering symptoms of COVID-19. Many doctors have seen an increase in patients with "long COVID" or Post-COVID Condition.
Fatigue, shortness of breath with exertion, tachycardia, brain fog, insomnia/sleep disturbances, gastrointestinal disorders, skin rashes, anxiety and depression are some of the persisting symptoms. Our goal is to assess the efficacy of various interventions in the treatment of "long COVID"/Post-COVID Condition.
For more information on current interventions, please visit the Clinical Trials registry, ClinicalTrials.gov, at: https://classic.clinicaltrials.gov/ct2/show/NCT05513560
More intervention targets will be tested more quickly and efficiently
More diverse patient population and sites will be included
Strengthen our existing knowledge translation plans so that therapies found to be beneficial can be implemented quickly.
Open to Canadian residents ages 18 years of age or older with a history of COVID-19 and lingering symptoms for longer than 3 months.
Participate in Our Study
Participants must be 18 years of age or older and must have had a history of COVID-19. Participants must also have had lingering symptoms for longer than three months. Enrollment coming soon!